샘플 요청 목록

 카트 문의
시장보고서
상품코드
1741992

유럽의 비침습성 환기 마스크 시장 예측(-2031년) - 지역별 분석(제품별, 용도별, 최종 사용자별)

Europe Non-Invasive Ventilation Masks Market Forecast to 2031 - Regional Analysis - by Product, Application, and End User
발행일: | 리서치사: The Insight Partners | 페이지 정보: 영문 147 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

유럽의 비침습성 환기 마스크 시장은 2023년 5억 7,458만 달러로 평가되었고, 2031년에는 9억 2,202만 달러에 이를 것으로 예측되며, 2023년부터 2031년까지 CAGR 6.1%로 추정됩니다.

재택치료 지향의 고조가 유럽의 비침습성 환기 마스크 시장을 견인

장기 요양 시설, 입원 재활 시설, 숙련 간호 시설에서 재택 요양 환경으로 이동함으로써 클라우드 및 이동성 주도형 의료기기는 환자와 의사와 더 나은 일관성 있고 적시에 상호 작용을 제공합니다. COVID-19의 유행은 병원의 병상 수 제한과 숙련된 의료 전문가의 부족으로 인해 가정 의료의 중요성을 유발했습니다.

게다가 COPD, 수면 무호흡 증후군, 기타 호흡기 질환을 앓고 있는 환자가, 집에서의 관리를 희망하는 케이스가 늘고 있습니다. 환자는 자주 병원을 방문하지 않고, 집에서 쾌적하게 NIV 치료를 받을 수 있습니다. 재택치료 제공업체는 종합적인 호흡 케어 플랜의 구성 요소로서, NIV 마스크를 처방하는 빈도를 높이고 있습니다.

그러므로 재택치료에 대한 견인력이 높아지고, 보다 고도로 합리적인 가격의, 간단하게 조작할 수 있는 재택용 디바이스에 대한 수요 증가에 의해 비침습성 환기 마스크 시장은 현저한 견인력을 늘리고 있습니다.

유럽의 비침습성 환기 마스크 시장 개요

유럽의 비침습성 환기 마스크 시장은 독일, 프랑스, 영국, 이탈리아, 스페인 및 기타 유럽으로 구분됩니다. Philips, Intersurgical, Hamilton Medical 등의 유력 기업의 존재, NIV 마스크 제조업체에 의한 전략적 개발 등입니다. 2020년 6워르 ReddyPort는 NIV의 성공을 돕고, 임상의가 환기 마스크를 통해 처치를 할 수 있도록 하는 솔루션인 ReddyPort Elbow의 CE 마크 승인을 취득했습니다. 이 제품 승인에 의해 동사는 유럽 연합(EU)을 비롯해, 루마니아, 스페인, 프랑스, 오스트리아 등 CE 마크 취득 지역 전역에서의 상품화가 가능하게 되었습니다.

유럽의 비침습성 환기 마스크 시장 수익과 2031년까지의 예측(금액)

유럽의 비침습성 환기 마스크 시장의 세분화

유럽의 비침습성 환기 마스크 시장은 제품, 용도, 최종 사용자, 국가로 분류됩니다.

제품별로는 유럽의 비침습성 환기 마스크 시장은 일회용형 비침습성 환기 마스크와 재사용형 비침습성 환기 마스크로 2분할 수 있습니다.

용도별로는 유럽의 비침습성 환기 마스크 시장은 수면 무호흡, 만성 폐색성 폐질환, 폐렴 등으로 구분됩니다.

최종 사용자별로 보면, 유럽의 비침습성 환기 마스크 시장은 병원 및 진료소, 재택치료, 기타로 구분됩니다.

국가별로 보면 유럽의 비침습성 환기 마스크 시장은 영국, 독일, 프랑스, 이탈리아, 스페인, 기타 유럽으로 구분됩니다. 독일이 2023년 유럽 비침습성 환기 마스크 시장에서 가장 큰 점유율을 차지하고 있습니다.

Air Liquide Medical Systems; Armstrong Medical Ltd; Besmed Health Business Corp; BMC Medical Co Ltd; DeVilbiss Healthcare LLC; Dimar SPA; Ltd; Koninklijke Philips NV; Medline Industries LP; ResMed Inc; Sleepnet Corporation; SunMed Group Holdings LLC(AirLife); and SURU INTERNATIONAL PVT.LTD. 등이 유럽의 비침습성 환기 마스크 시장에서 사업을 전개하고 있는 주요 기업입니다.

목차

제1장 서론

제2장 주요 요약

  • 주요 인사이트

제3장 분석 방법

  • 2차 조사
  • 1차 조사
    • 가설의 책정
    • 거시경제 요인분석
    • 기초 수치의 개발
    • 데이터의 삼각측량
    • 국가 레벨 데이터

제4장 유럽의 비침습성 환기 마스크 시장의 정세

  • PEST 분석

제5장 유럽의 비침습성 환기 마스크 시장 : 주요 시장 역학

  • 유럽의 비침습성 환기 마스크 시장 : 주요 시장 역학
  • 시장 성장 촉진요인
    • 호흡기 질환의 유병률 증가
    • 재택치료 지향 증가
  • 시장 성장 억제요인
    • NIV 마스크에 수반하는 부작용
  • 시장 기회
    • NIV 마스크의 채용 증가
  • 향후의 동향
    • 기술 진보의 진전
  • 성장 촉진요인과 억제요인의 영향

제6장 유럽의 비침습성 환기 마스크 시장 분석

  • 비침습성 환기 마스크 시장의 수익(2021-2031년)
  • 비침습성 환기 마스크 시장 예측 및 분석

제7장 유럽의 비침습성 환기 마스크 시장 분석 : 제품별

  • 일회용형 비침습성 환기 마스크
  • 재사용형 비침습성 환기 마스크

제8장 유럽의 비침습성 환기 마스크 시장 분석 : 용도별

  • 수면 무호흡증후군
  • 만성 폐색성 폐질환
  • 폐렴
  • 기타

제9장 유럽의 비침습성 환기 마스크 시장 분석 : 최종 사용자별

  • 병원 및 진료소
  • 재택치료
  • 기타

제10장 유럽의 비침습성 환기 마스크 시장 : 국가별 분석

  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타 유럽

제11장 업계 정세

  • 비침습성 환기 마스크 시장의 성장 전략
  • 유기적 성장 전략
  • 무기적 성장 전략

제12장 기업 프로파일

  • Hamilton Medical AG
  • ResMed Inc
  • Fisher & Paykel Healthcare Corp Ltd
  • Air Liquide Medical Systems
  • Dragerwerk AG & Co KGaA
  • Intersurgical Ltd
  • BMC Medical Co Ltd
  • DeVilbiss Healthcare LLC
  • Armstrong Medical Ltd
  • Koninklijke Philips NV
  • Besmed Health Business Corp
  • Sleepnet Corporation.
  • SunMed Group Holdings LLC(AirLife)
  • Dimar SPA
  • Hangzhou Formed Medical Devices Co., Ltd
  • SURU INTERNATIONAL PVT. LTD.
  • Medline Industries LP

제13장 부록

JHS 25.06.13

The Europe non-invasive ventilation masks market was valued at US$ 574.58 million in 2023 and is expected to reach US$ 922.02 million by 2031; it is estimated to register a CAGR of 6.1% from 2023 to 2031.

Growing Inclination Towards Home Healthcare Drive Europe Cosmetic Preservatives Market

A shift from long-term facilities, inpatient rehabilitation, and skilled nursing facilities to home care settings results in a better, consistent, and timely interaction between patient and doctor owing to the cloud and mobility-driven medical devices. The COVID-19 outbreak triggered home healthcare's importance due to limited hospital bed capacity and a scarcity of skilled healthcare professionals. With the help of home healthcare, healthcare professionals can monitor patient's vitals remotely and avoid hospital admissions.

Moreover, patients with conditions such as COPD, sleep apnea, and other respiratory issues are increasingly expressing a preference for at-home management of their ailments. Patients can use NIV therapy in the comfort of their homes without having to make frequent visits to the hospital. Home healthcare providers are prescribing NIV masks more frequently as a component of all-encompassing respiratory care plans.

Therefore, due to the growing traction toward home healthcare and increasing demand for more advanced, affordable, and easily navigable devices at home, the market for Noninvasive ventilation masks is gaining noticeable traction.

Europe Cosmetic Preservatives Market Overview

The Europe noninvasive ventilation masks market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The regional market is driven due to the increasing prevalence of chronic respiratory diseases, including COPD, OSA, acute respiratory failure (ARF), the presence of prominent players such as Philips, Intersurgical, and Hamilton Medical in the Europe noninvasive ventilation masks market, and strategic developments made by NIV masks manufacturers. In June 2020, ReddyPort, a medical technology company, received CE Mark approval for ReddyPort Elbow, a solution that supports NIV success and allows clinicians to perform procedures through the ventilation mask. This product approval allows the company to commercialize it across the European Union and other CE Mark geographies, including Romania, Spain, France, and Austria.

Europe Cosmetic Preservatives Market Revenue and Forecast to 2031 (US$ Million)

Europe Cosmetic Preservatives Market Segmentation

The Europe non-invasive ventilation masks market is categorized into product, application, end user, and country.

By product, the Europe non-invasive ventilation masks market is bifurcated into noninvasive ventilation disposable mask and noninvasive ventilation reusable mask. The noninvasive ventilation disposable mask segment held a larger share of the Europe non-invasive ventilation masks market share in 2023.

In terms of application, the Europe non-invasive ventilation masks market is segmented into sleep apnea, chronic obstructive pulmonary disease, pneumonia, and others. The sleep apnea segment held the largest share of the Europe non-invasive ventilation masks market share in 2023.

Based on end user, the Europe non-invasive ventilation masks market is segmented into hospitals and clinics, home care, and others. The hospitals and clinics segment held the largest share of the Europe non-invasive ventilation masks market share in 2023.

Based on country, the Europe non-invasive ventilation masks market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany segment held the largest share of Europe non-invasive ventilation masks market in 2023.

Air Liquide Medical Systems; Armstrong Medical Ltd; Besmed Health Business Corp; BMC Medical Co Ltd; DeVilbiss Healthcare LLC; Dimar S.P.A.; Dragerwerk AG & Co KGaA; Fisher & Paykel Healthcare Corp Ltd; Hamilton Medical AG; Hangzhou Formed Medical Devices Co., Ltd; Intersurgical Ltd; Koninklijke Philips NV; Medline Industries LP; ResMed Inc; Sleepnet Corporation; SunMed Group Holdings LLC ( AirLife); and SURU INTERNATIONAL PVT. LTD. are some of the leading companies operating in the Europe non-invasive ventilation masks market.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Non-Invasive Ventilation Masks Market Landscape

  • 4.1 PEST Analysis

5. Europe Non-Invasive Ventilation Masks Market - Key Market Dynamics

  • 5.1 Europe Non-Invasive Ventilation Masks Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Prevalence of Respiratory Diseases
    • 5.2.2 Growing Inclination Towards Home Healthcare
  • 5.3 Market Restraints
    • 5.3.1 Side Effects Associated with NIV Masks
  • 5.4 Market Opportunities
    • 5.4.1 Increasing Adoption of NIV Masks
  • 5.5 Future Trends
    • 5.5.1 Rising Technological Advancements
  • 5.6 Impact of Drivers and Restraints:

6. Europe Non-Invasive Ventilation Masks Market - Analysis

  • 6.1 Europe Non-Invasive Ventilation Masks Market Revenue (US$ Million), 2021-2031
  • 6.2 Europe Non-Invasive Ventilation Masks Market Forecast Analysis

7. Europe Non-Invasive Ventilation Masks Market Analysis - by Product

  • 7.1 Non-Invasive Ventilation Disposable Mask
    • 7.1.1 Overview
    • 7.1.2 Non-Invasive Ventilation Disposable Mask: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Non-Invasive Ventilation Reusable Mask
    • 7.2.1 Overview
    • 7.2.2 Non-Invasive Ventilation Reusable Mask: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Non-Invasive Ventilation Masks Market Analysis - by Application

  • 8.1 Sleep Apnea
    • 8.1.1 Overview
    • 8.1.2 Sleep Apnea: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Chronic Obstructive Pulmonary Disease
    • 8.2.1 Overview
    • 8.2.2 Chronic Obstructive Pulmonary Disease: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Pneumonia
    • 8.3.1 Overview
    • 8.3.2 Pneumonia: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Non-Invasive Ventilation Masks Market Analysis - by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Overview
    • 9.1.2 Hospitals and Clinics: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Home Care
    • 9.2.1 Overview
    • 9.2.2 Home Care: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Non-Invasive Ventilation Masks Market - Country Analysis

  • 10.1 Europe
    • 10.1.1 Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 United Kingdom: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 United Kingdom: Europe Non-Invasive Ventilation Masks Market Share - by Product
        • 10.1.1.2.2 United Kingdom: Europe Non-Invasive Ventilation Masks Market Share - by Application
        • 10.1.1.2.3 United Kingdom: Europe Non-Invasive Ventilation Masks Market Share - by End User
      • 10.1.1.3 Germany: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 Germany: Europe Non-Invasive Ventilation Masks Market Share - by Product
        • 10.1.1.3.2 Germany: Europe Non-Invasive Ventilation Masks Market Share - by Application
        • 10.1.1.3.3 Germany: Europe Non-Invasive Ventilation Masks Market Share - by End User
      • 10.1.1.4 France: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 France: Europe Non-Invasive Ventilation Masks Market Share - by Product
        • 10.1.1.4.2 France: Europe Non-Invasive Ventilation Masks Market Share - by Application
        • 10.1.1.4.3 France: Europe Non-Invasive Ventilation Masks Market Share - by End User
      • 10.1.1.5 Italy: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.5.1 Italy: Europe Non-Invasive Ventilation Masks Market Share - by Product
        • 10.1.1.5.2 Italy: Europe Non-Invasive Ventilation Masks Market Share - by Application
        • 10.1.1.5.3 Italy: Europe Non-Invasive Ventilation Masks Market Share - by End User
      • 10.1.1.6 Spain: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.6.1 Spain: Europe Non-Invasive Ventilation Masks Market Share - by Product
        • 10.1.1.6.2 Spain: Europe Non-Invasive Ventilation Masks Market Share - by Application
        • 10.1.1.6.3 Spain: Europe Non-Invasive Ventilation Masks Market Share - by End User
      • 10.1.1.7 Rest of Europe: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.7.1 Rest of Europe: Europe Non-Invasive Ventilation Masks Market Share - by Product
        • 10.1.1.7.2 Rest of Europe: Europe Non-Invasive Ventilation Masks Market Share - by Application
        • 10.1.1.7.3 Rest of Europe: Europe Non-Invasive Ventilation Masks Market Share - by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Noninvasive Ventilation Mask Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Hamilton Medical AG
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 ResMed Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Fisher & Paykel Healthcare Corp Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Air Liquide Medical Systems
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Dragerwerk AG & Co KGaA
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Intersurgical Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 BMC Medical Co Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 DeVilbiss Healthcare LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Armstrong Medical Ltd
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Koninklijke Philips NV
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Besmed Health Business Corp
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Sleepnet Corporation.
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 SunMed Group Holdings LLC ( AirLife)
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 Dimar S.P.A.
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 Financial Overview
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments
  • 12.15 Hangzhou Formed Medical Devices Co., Ltd
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Products and Services
    • 12.15.4 Financial Overview
    • 12.15.5 SWOT Analysis
    • 12.15.6 Key Developments
  • 12.16 SURU INTERNATIONAL PVT. LTD.
    • 12.16.1 Key Facts
    • 12.16.2 Business Description
    • 12.16.3 Products and Services
    • 12.16.4 Financial Overview
    • 12.16.5 SWOT Analysis
    • 12.16.6 Key Developments
  • 12.17 Medline Industries LP
    • 12.17.1 Key Facts
    • 12.17.2 Business Description
    • 12.17.3 Products and Services
    • 12.17.4 Financial Overview
    • 12.17.5 SWOT Analysis
    • 12.17.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 List of Abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제